Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies

G. Schwartsmann, P. Dodion, J.B. Vermorken, W.W. ten Bokkel Huinink, J. Joggi, B. Winograd, H. Gall, G. Simonetti, W.J.F. van der Vijgh, M.B. van Hennik, N. Crespeigne, H.M. Pinedo

Research output: Contribution to journalArticleAcademicpeer-review

7 Downloads (Pure)
Original languageEnglish
Pages (from-to)345-351
JournalCancer Chemotherapy and Pharmacology
Volume25
Publication statusPublished - 1990

Cite this

Schwartsmann, G., Dodion, P., Vermorken, J. B., ten Bokkel Huinink, W. W., Joggi, J., Winograd, B., ... Pinedo, H. M. (1990). Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies. Cancer Chemotherapy and Pharmacology, 25, 345-351.
Schwartsmann, G. ; Dodion, P. ; Vermorken, J.B. ; ten Bokkel Huinink, W.W. ; Joggi, J. ; Winograd, B. ; Gall, H. ; Simonetti, G. ; van der Vijgh, W.J.F. ; van Hennik, M.B. ; Crespeigne, N. ; Pinedo, H.M. / Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies. In: Cancer Chemotherapy and Pharmacology. 1990 ; Vol. 25. pp. 345-351.
@article{eb12c93f66974fe8b98b50dc4813e036,
title = "Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies",
author = "G. Schwartsmann and P. Dodion and J.B. Vermorken and {ten Bokkel Huinink}, W.W. and J. Joggi and B. Winograd and H. Gall and G. Simonetti and {van der Vijgh}, W.J.F. and {van Hennik}, M.B. and N. Crespeigne and H.M. Pinedo",
year = "1990",
language = "English",
volume = "25",
pages = "345--351",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",

}

Schwartsmann, G, Dodion, P, Vermorken, JB, ten Bokkel Huinink, WW, Joggi, J, Winograd, B, Gall, H, Simonetti, G, van der Vijgh, WJF, van Hennik, MB, Crespeigne, N & Pinedo, HM 1990, 'Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies' Cancer Chemotherapy and Pharmacology, vol. 25, pp. 345-351.

Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies. / Schwartsmann, G.; Dodion, P.; Vermorken, J.B.; ten Bokkel Huinink, W.W.; Joggi, J.; Winograd, B.; Gall, H.; Simonetti, G.; van der Vijgh, W.J.F.; van Hennik, M.B.; Crespeigne, N.; Pinedo, H.M.

In: Cancer Chemotherapy and Pharmacology, Vol. 25, 1990, p. 345-351.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies

AU - Schwartsmann, G.

AU - Dodion, P.

AU - Vermorken, J.B.

AU - ten Bokkel Huinink, W.W.

AU - Joggi, J.

AU - Winograd, B.

AU - Gall, H.

AU - Simonetti, G.

AU - van der Vijgh, W.J.F.

AU - van Hennik, M.B.

AU - Crespeigne, N.

AU - Pinedo, H.M.

PY - 1990

Y1 - 1990

M3 - Article

VL - 25

SP - 345

EP - 351

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

ER -

Schwartsmann G, Dodion P, Vermorken JB, ten Bokkel Huinink WW, Joggi J, Winograd B et al. Phase I study of Brequinar sodium (NSC368390) in patients with solid malignancies. Cancer Chemotherapy and Pharmacology. 1990;25:345-351.